Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Call-On-Doc vs FuturHealth

Call-On-Doc
Graded #297

Lower grade

vs+4.299999999999997
FuturHealth
Graded #215

Higher grade

The verdict

FuturHealth takes it — 65.6/100 to 61.3/100.

FuturHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFuturHealth +15
45
60
Dose & formulationFuturHealth +28
53
81
Clinical oversightCall-On-Doc +18
85
67
Labs & monitoringFuturHealth +7
54
61
FulfillmentCall-On-Doc +21
83
62
Contract termsEven
55
55
Call-On-Doc · left barFuturHealth · right bar

The numbers

MetricCall-On-DocFuturHealth
WeighScore61.3/10065.6/100
GradeCC
Scorecard rank#297#215
SemaglutideNot disclosed$199/mo (compounded)
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Call-On-Doc

Graded #297 · C

Strengths

  • Prescribes branded GLP-1s (Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda)
  • Available in all 50 states plus DC
  • Fast, no-appointment visits usually completed within two hours
  • Patients can use insurance at the pharmacy plus an Rx savings card
  • Large, well-reviewed platform (2M+ patients, 800k+ 5-star reviews)

Where it loses points

  • Specific visit fee and medication pricing not posted on homepage
  • Credit card required for the visit fee
  • Multi-condition focus rather than weight-loss specialist
  • Provider credentials described only generically
FuturHealth

Graded #215 · C

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

Where it loses points

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard